Evidence map›Paper›PMID 42643356›Full record

ArticleFrontiers in neurology2026

A nomogram model for predicting seizure control in status epilepticus: development and risk factor analysis.

Zhenyu Huang, Shenggen Chen, Hanbin Lin, Yuying Zhang, Luyan Wu, Wanhui Lin, Chaofeng Zhu, Huapin Huang

Abstract read
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenyu Huang *Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Shenggen Chen *Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Hanbin Lin *Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Yuying ZhangDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Luyan WuDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wanhui LinDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chaofeng ZhuDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Huapin HuangDepartment of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To explore the risk factors impacting control of seizures in status epilepticus (SE) and to construct a valid nomogram for predicting the prognosis. Methods: In this retrospective study, we analyzed the patients with SE who were hospitalized in Fujian Medical University Union Hospital from January 2017 to December 2022. Two separate groups of data are created: one for model development and the other for model validation. Results: A total of 272 patients with SE were enrolled in this study, of which 89 had poorly-controlled seizures at discharge. Six potential risk predictors were identified through LASSO regression. After validation by univariate logistic regression ( Conclusion: The proposed nomogram, constructed based on four independent risk factors, exhibits acceptable discriminative ability and clinical benefit. The risk of poorly-controlled seizures in individual SE patients can be predicted through the nomogram. The model may facilitate the early and timely identification of high-risk patients.

Indexed as

NomogramsSeizuresStatus EpilepticusAdultAgedFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk Factorsnomogramprognosisrisk factorseizure controlstatus epilepticus

Identifiers

PMID42643356
PMCPMC13503241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.